Characterization of human cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (hCTLA4Ig) expressed in transgenic rice cell suspension cultures

Biotechnology Letters

Volumn 28, Issue 24, 2006, Pages 2039-2048

  Jung, Hahn Sun ^a   Koo, Jae Kyung ^a   Lee, Song Jae ^a   Park, Cheon Ik ^a   Shin, Ju Yeop ^a   Kim, Myung Hwan ^a   Tan, Hyun Kwang ^a   Lim, Sang Min ^a   Kim, Dong Il ^b  

^a Boryung Pharm Co Ltd   (South Korea)

^b Inha University   (South Korea)

Author keywords

Human CTLA4Ig; Immunosuppressive effect; Oryza sativa; Plant cell suspension culture; Surface plasmon resonance

Indexed keywords

CELLS; CYTOLOGY; IMMUNOLOGY; PLANT CELL CULTURE; PROTEINS; SURFACE PLASMON RESONANCE; TOXIC MATERIALS;

HUMAN CTLA4IG; IMMUNOSUPPRESSIVE EFFECTS; ORYZA SATIVA; PLANT CELL SUSPENSION CULTURES;

ANTIGENS;

ABATACEPT; ANTIBODY CONJUGATE; NITRIC OXIDE; PLANTIBODY; RECOMBINANT PROTEIN;

ANIMAL; ANTIBODY AFFINITY; ARTICLE; CELL CULTURE; CHO CELL; COMPARATIVE STUDY; CRICETULUS; CULTURE TECHNIQUE; EVALUATION; FEASIBILITY STUDY; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PROTEIN ENGINEERING; RICE; TRANSGENIC PLANT;

ANIMALS; ANTIBODY AFFINITY; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FEASIBILITY STUDIES; GENE EXPRESSION REGULATION, PLANT; HUMANS; IMMUNOCONJUGATES; MICE; NITRIC OXIDE; ORYZA SATIVA; PLANTIBODIES; PLANTS, GENETICALLY MODIFIED; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

ORYZA SATIVA;

EID: 33845294049     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-006-9191-7     Document Type: Article

References (19)

1. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JK (2000) Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 192:681-693
2. Bluestone JA, St. Clair EW, Turka LA (2006) CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24:233-238
3. Cabanes-Macheteau M, Fitchette-Laine AC, Loutelier-Bourhis C, Lange C, Vine ND, Ma JK, Lerouge P, Faye L (1999) N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 9:365-372
4. Freeman G, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadler LM (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523-532
5. Garcia-Casado G, Sanchez-Monge R, Chrispeels MJ, Armentia A, Salcedo G, Gomez L (1996) Role of complex asparagines-linked glycans in the allergenicity of plant glycoproteins. Glycobiology 4:471-477
6. Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, Cosand W, Linsley PS (1996) Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem 271:26762-26771
7. Guillot C, Mathieu P, Coathalem H, Mauff BL, Castro MG, Tesson M, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I (2000) Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 164:5258-5268
8. Hellwig S, Drossard J, Twyman RM, Fischer R (2004) Plant cell cultures for the production of recombinant proteins. Nature Biotechnol 22:1415-1422
9. Huang J, Wu L, Yalda D, Adkins Y, Kelleher SL, Crane M, Lonnerdal B, Rodriguez RL, Huang N (2002) Expression of functional recombinant human lysozyme in transgenic rice cell culture. Transgenic Res 11:229-239
10. Kremer JM, Westhovens R, Leon M, Giorgio ED, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah IF, Williams GR, Becker JC, Hagerty DT, Moreland LW (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349:1907-1915
11. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721-730
12. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R (1994) Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793-801
13. Ma JKC, Barros E, Bock R, Christou P, Dale PJ, Dix PJ, Fischer R, Irwin J, Mahoney R, Pezzotti M, Schillberg S, Sparrow P, Stoger E, Twyman RM (2005) Molecular farming for new drugs and vaccines. EMBO Rep 6:593-599
14. Mari A, Lacovacci P, Afferni C, Barletta B, Tinghino R, Di Felice G, Pini C (1999) Specific IgE to cross-reactive carbohydrate determinants strongly affects the in vitro diagnosis of allergic diseases. J Allergy Clin Immunol 103:1005-1011
15. Morton PA, Fu XT, Stewart JA, Giacoletto KS, White SL, Leyath CE, Evans RJ, Shieh J, Karr RW (1996) Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol 156:1047-1054
16. Shin YJ, Hong SY, Kwon TH, Jang YS, Yang MS (2003) High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol Bioeng 82:778-783
17. 1-antitrypsin by plant cell culture. Appl Microbiol Biotechnol 52:516-523
18. Thomson JA, Abdullah R, Cocking EC (1986) Protoplast culture of rice (Oryza sativa L.) using media solidified with agarose. Plant Sci 47:123-133
19. Tomasoni S, Azzollini N, Casiraghi F, Capogrossi MC, Renyzzu G, Benigni A (2000) CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 11:747-752